| ||
Catalyst Pharmaceutical Partners Provides Update on Research and ... NASDAQ 11, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc.(Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare (orphan) neurological diseases and ... See all stories on this topic » | ||
Bearish MACD for Raptor Pharmaceutical Corp. Zacks.com Raptor Pharmaceutical Corp.'s (RPTP - Snapshot Report) MACD indicator has moved into bearish territory with a reading of –0.1122. The Zacks Rank # 4 ("Sell") stock decreased more than 0.95% to $5.11 in morning trade. The Zacks Consensus Estimate on ... See all stories on this topic » | ||
MWV Expands Pharmaceutical Manufacturing Centre of Excellence Packaging Europe The Centre is the core for MWV's global pharmaceutical dispensing systems manufacturing network. The $7.5 million project includes expanding clean room molding and assembly capacity, and the introduction of a state-of-the-art logistics system to ... See all stories on this topic » | ||
Drug Discovery Initiative Launched in Europe Pharmaceutical Technology Magazine (blog) An international consortium of pharmaceutical companies, academia, research organisations and other related entities have launched a new platform to help enhance drug discovery in Europe. The consortium, the European Lead Factory, aims to help ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment